Cureus

Incretin-Based Therapies Versus Bariatric and Metabolic Surgery for Obesity and Type 2 Diabetes Mellitus: A Head-to-Head Systematic Review of Glycaemic, Cardiovascular, Hepatic, Weight, and Quality-of-Life Outcomes

By Omar Alsayed, Mohammed Zaid Jarai, Sarrosh Khan, Mariam Sandal

Figure 1. PRISMA 2020 Flow Diagram of Study Selection Process. — Figure 1. PRISMA 2020 Flow Diagram of Study Selection Process.PRISMA 2020 Flow Diagram of Study Selection Process.Alsayed et al.

Systematic review of studies in peopleInterventions

Declared no competing interests

The paper

Omar Alsayed, Mohammed Zaid Jarai, Sarrosh Khan, Mariam Sandal

Dubai Health Authority

Cureus, 1 Aug 2026

doi.org/10.7759/cureus.113777 PubMed 42677221

The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes